AKTX

Akari Therapeutics, Plc

AKTX · CIK 1541157 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20142024
Net Income−$20M
20142024
Operating CF−$13M
20142024
Free Cash Flow
20142024

Income Statement

MetricFY 2024↕FY 2023↕FY 2015↕FY 2014↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.0B$0.0B$0.0B$0.0B
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$0.00$0.00——
EPS (Diluted)$0.00$0.00——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2015↕FY 2014↕
Total Assets$0.1B$0.0B$0.1B$0.0B
Current Assets$0.0B$0.0B$0.1B$0.0B
Cash & Equivalents$0.0B$0.0B$0.1B$0.0B
Total Liabilities$0.0B$0.0B$0.0B—
Current Liabilities$0.0B—$0.0B$0.0B
Stockholders' Equity$0.0B$-0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2015↕FY 2014↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B—$0.0B$-0.0B
Capital Expenditures——$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.1B$0.0B
← Companies